Waldor_1983_Proc.Natl.Acad.Sci.U.S.A_80_2713

Reference

Title : In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor - Waldor_1983_Proc.Natl.Acad.Sci.U.S.A_80_2713
Author(s) : Waldor MK , Sriram S , McDevitt HO , Steinman L
Ref : Proc Natl Acad Sci U S A , 80 :2713 , 1983
Abstract :

A monoclonal antibody to I-A gene products of the immune response gene complex attenuates both humoral and cellular responses to acetylcholine receptor and appears to suppress clinical manifestations of experimental autoimmune myasthenia gravis. This demonstrates that use of antibodies against immune response gene products that are associated with susceptibility to disease may be feasible for therapy in autoimmune conditions such as myasthenia gravis.

PubMedSearch : Waldor_1983_Proc.Natl.Acad.Sci.U.S.A_80_2713
PubMedID: 6405386

Related information

Citations formats

Waldor MK, Sriram S, McDevitt HO, Steinman L (1983)
In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor
Proc Natl Acad Sci U S A 80 :2713

Waldor MK, Sriram S, McDevitt HO, Steinman L (1983)
Proc Natl Acad Sci U S A 80 :2713